Literature DB >> 2864899

Hypogammaglobulinaemia and thrombocytopenia associated with sulphasalazine therapy in rheumatoid arthritis.

M Farr, E Tunn, P A Bacon, D H Smith.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2864899      PMCID: PMC1001752          DOI: 10.1136/ard.44.10.723-b

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  7 in total

1.  Sulphasalazine induced selective IgA deficiency in rheumatoid arthritis.

Authors:  J P Delamere; M Farr; K A Grindulis
Journal:  Br Med J (Clin Res Ed)       Date:  1983-05-14

2.  Hypogammaglobulinaemia associated with gold therapy.

Authors:  T Hunter
Journal:  Ann Rheum Dis       Date:  1985-03       Impact factor: 19.103

3.  Hypogammaglobulinaemia associated with gold therapy.

Authors:  A K So; S A Peskett; A D Webster
Journal:  Ann Rheum Dis       Date:  1984-08       Impact factor: 19.103

Review 4.  Sulphasalazine: a 'new' antirheumatic drug.

Authors:  T Pullar; H A Capell
Journal:  Br J Rheumatol       Date:  1984-02

5.  The long term effects of sulphasalazine in the treatment of rheumatoid arthritis and a comparative study with penicillamine.

Authors:  M Farr; E Tunn; A P Crockson; P A Bacon
Journal:  Clin Rheumatol       Date:  1984-12       Impact factor: 2.980

6.  Adverse reactions to salicylazosulfapyridine (azulfidine) in the treatment of ulcerative colitis.

Authors:  J R Collins
Journal:  South Med J       Date:  1968-04       Impact factor: 0.954

7.  Sulphasalazine: a safe, effective agent for prolonged control of rheumatoid arthritis. A comparison with sodium aurothiomalate.

Authors:  D E Bax; R S Amos
Journal:  Ann Rheum Dis       Date:  1985-03       Impact factor: 19.103

  7 in total
  3 in total

Review 1.  Genetics of IgA deficiency and common variable immunodeficiency.

Authors:  H W Schroeder
Journal:  Clin Rev Allergy Immunol       Date:  2000-10       Impact factor: 8.667

2.  The clinical value of measuring immunoglobulins when assessing penicillamine therapy in rheumatoid arthritis.

Authors:  A Williams; D L Scott; A Greenwood; E C Huskisson
Journal:  Clin Rheumatol       Date:  1988-09       Impact factor: 2.980

3.  Thrombocytopenia due to aurothioglucose, sulphasalazine, and hydroxychloroquine.

Authors:  M J Wijnands; W A Allebes; A M Boerbooms; L B van de Putte; P L van Riel
Journal:  Ann Rheum Dis       Date:  1990-10       Impact factor: 19.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.